The role of epigenetic modifications in autism

Not Applicable

• Conditions: Nervous System Diseases; Autism spectrum disorder

• Registration Number: PACTR201705002282393
• Lead Sponsor: the Vice Dean Research Office.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-05-10
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

a. All enrolled children with ASD will be:
1-Exhibit symptoms within the typical triad of autistic traits: communication impairment, social deficits, and ritualistic interests.
2-2-6 years old.
3-Drug-naïve.

Exclusion Criteria

b.
The control subjects will also clinically examined by the psychiatrist to exclude any sub-clinical autistic features. Children with ASD and controls will excluded from the study if
2-They receive treatment for any reason.
3--Endocrinological disease, mental retardation, communication disorder, psychotic disorder, attention deficit hyperactivity disorder and learning disorders seen in the children or their family members.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The difference in mean percentage of gene methylation.